Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Accured Expenses: 2017-2024

Historic Change in Accured Expenses for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $16.0 million.

  • Cogent Biosciences' Change in Accured Expenses rose 253.84% to $1.2 million in Q4 2021 from the same period last year, while for Dec 2021 it was $3.4 million, marking a year-over-year increase of 245.88%. This contributed to the annual value of $16.0 million for FY2024, which is 95.30% up from last year.
  • As of FY2024, Cogent Biosciences' Change in Accured Expenses stood at $16.0 million, which was up 95.30% from $8.2 million recorded in FY2023.
  • Over the past 5 years, Cogent Biosciences' Change in Accured Expenses peaked at $16.0 million during FY2024, and registered a low of -$2.4 million during FY2020.
  • Moreover, its 3-year median value for Change in Accured Expenses was $9.6 million (2022), whereas its average is $11.2 million.
  • Per our database at Business Quant, Cogent Biosciences' Change in Accured Expenses tumbled by 233.64% in 2020 and then surged by 245.88% in 2021.
  • Over the past 5 years, Cogent Biosciences' Change in Accured Expenses (Yearly) stood at -$2.4 million in 2020, then spiked by 245.88% to $3.4 million in 2021, then soared by 179.39% to $9.6 million in 2022, then fell by 14.77% to $8.2 million in 2023, then skyrocketed by 95.30% to $16.0 million in 2024.